ALTERNATE HEALTH'S STATEPASS EMR AND CANNABIS COMPLIANCE BLOCKCHAIN TAKES ON NEW YORK MARKET, BEGINS PHYSICIAN ONBOARDING
ALTERNATE HEALTH’S STATEPASS EMR AND CANNABIS
COMPLIANCE BLOCKCHAIN TAKES ON NEW YORK MARKET, BEGINS PHYSICIAN
ONBOARDING
San Antonio, TX -- April 5, 2018 --
InvestorsHub NewsWire -- Alternate Health Corp ("Alternate
Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international
software solutions leader in the medical cannabis industry, today
announced that the Company is expanding its StatePass medical
cannabis Electronic Medical Records (EMR) blockchain system in New
York, commencing physician onboarding and initial service
testing.
“We have already identified several cannabis
physicians to begin service testing StatePass in New York, where
they will use the EMR for their current cannabis patients and
provide feedback so our programming team can optimize the system
for statewide use,” says Dr. Michael Murphy, Chairman and CEO of
Alternate Health. “Based on the positive feedback we have already
received from physicians, we are confident that our presence in the
New York market will expand rapidly.”
StatePass is the only EMR and blockchain-enabled
software solution specifically designed for the medical cannabis
industry. A complete practice management tool, StatePass ensures
strict regulatory compliance with a focus on improving patient
outcomes. StatePass is also an ideal software solution for highly
regulated markets, like New York, with an easy-to-use interface
that allows physicians to personalize their patients’ treatment
options with built-in, automated compliance
reporting.
The arrival of StatePass in the New York market
follows the success of the system’s original version CanaPass and
the Florida-specific adaptation – FlorPass. Boosted by
the American Medical Marijuana Physicians
Association’s recent endorsement of FlorPass, the system is rapidly expanding across
Florida, with AMMPA President Dr.
Orlando Florete declaring: “We believe that CanaPass will help
empower these physicians with the tools required to effectively and
compliantly help those patients in need.”
With automated reporting and compliance
features, StatePass navigates New York’s legal environment,
taxation rules, and state-specific medical cannabis regulations.
StatePass also records patient information through a distributed
blockchain ledger, ensuring industry-leading data security. This
unique suite of software services gives physicians the confidence
and peace-of-mind to focus on providing the best treatment to their
patients.
“Our New York team is working closely with
physicians to familiarize them with the StatePass system and
demonstrate how it can be a tremendous asset in enhancing their
medical cannabis practices,” says Jay Briggs, Vice President of
Operations for Alternate Health. “We are very excited to continue
developing our network of physicians and industry experts as we
deliver a best-in-class EMR solution.”
About StatePass
StatePass is the U.S. equivalent of Alternate
Health's cornerstone CanaPass Cannabis Compliance technology.
Alternate Health's CanaPass system is currently live nationwide in
Canada through a partnership with National Access Cannabis (‘NAC'),
Canada's largest chain of medical cannabis clinics. Listed on the
TSX Venture Exchange, NAC is currently expanding into recreational
markets. CanaPass will launch its recreational adaptation in all
future NAC recreational locations.
About Alternate
Health
Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health
has established multiple arms-length operations within the medical
cannabis industry, each of which drives consumers, data and
strategic opportunities to the company’s other verticals. This
sophisticated cross-integration of the company’s enterprises has
positioned Alternate Health as one of the only cannabis companies
that delivers consistent revenue and intellectual property without
growing, manufacturing or distributing the cannabis plant. Through
its software solutions, data analytics, and patented delivery
systems, Alternate Health’s goal is to be the global authority on
scientific and clinical support for cannabis in regulated markets.
Alternate Health is well positioned to reinvest internal operating
cash flow in its platform over the long term, creating an
attractive investment profile for its
shareholders.
Alternate Health resides in the cannabis sector
along with companies like GW Pharmaceuticals, AXIM Biotechnologies
Inc., Canopy Growth Corporation, and Aphria Inc. Alternate Health
is differentiated from other cannabis companies by its focus on
ancillary services for patients, healthcare professionals and
regulatory providers rather than selling a commodity. For more
information about Alternate Health Corp.,
visit www.alternatehealth.ca.
Investor Relations
Contact:
Nancy Goertzen, CPIR
1.604.512.7122 | n.goertzen@alternatehealth.ca
Jim
Griffiths, Director
1.416.607.5757 | j.griffiths@alternatehealth.ca
Neither the CSE nor its Regulation Services
Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this
release. Statements included in this announcement, including
statements concerning our plans, intentions and expectations, which
are not historical in nature are intended to be, and are hereby
identified as “forward-looking statements”. Forward-looking
statements may be identified by words including “anticipates”,
“believes”, “intends”, “estimates”, “expects” and similar
expressions. The Company cautions readers that forward-looking
statements, including without limitation those relating to the
Company’s future operations, business prospects and financing
plans, are subject to certain risks and uncertainties that could
cause actual results to differ materially from those indicated in
the forward looking statements.
Alternate Health (CSE:AHG)
過去 株価チャート
から 11 2024 まで 12 2024
Alternate Health (CSE:AHG)
過去 株価チャート
から 12 2023 まで 12 2024